Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1954 1
1955 1
1958 1
1968 1
1969 1
1971 1
1972 2
1973 3
1974 2
1975 1
1976 3
1978 1
1979 2
1980 1
1981 7
1982 1
1983 7
1984 10
1985 9
1986 11
1987 8
1988 12
1989 13
1990 9
1991 8
1992 13
1993 14
1994 23
1995 25
1996 28
1997 14
1998 12
1999 24
2000 24
2001 23
2002 14
2003 23
2004 21
2005 23
2006 16
2007 15
2008 22
2009 19
2010 18
2011 15
2012 21
2013 16
2014 22
2015 17
2016 18
2017 18
2018 17
2019 10
2020 8
2021 13
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

641 results
Results by year
Filters applied: . Clear all
Page 1
Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, Psimaras D, Alentorn A. Dade M, et al. Among authors: delattre jy. Int J Mol Sci. 2020 May 24;21(10):3701. doi: 10.3390/ijms21103701. Int J Mol Sci. 2020. PMID: 32456344 Free PMC article. Review.
Recommended diagnostic criteria for paraneoplastic neurological syndromes.
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. Graus F, et al. Among authors: delattre jy. J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40. doi: 10.1136/jnnp.2003.034447. J Neurol Neurosurg Psychiatry. 2004. PMID: 15258215 Free PMC article.
Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, Karachi C, Leclercq D, Lafon C, Chapelon JY, Capelle L, Cornu P, Sanson M, Hoang-Xuan K, Delattre JY, Idbaih A. Carpentier A, et al. Among authors: delattre jy. Sci Transl Med. 2016 Jun 15;8(343):343re2. doi: 10.1126/scitranslmed.aaf6086. Sci Transl Med. 2016. PMID: 27306666 Clinical Trial.
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. Appay R, et al. Among authors: delattre jy. Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124. Neuro Oncol. 2019. PMID: 31832685 Free PMC article.
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre JY, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Enting RH, French PJ, Dinjens WN, Vecht CJ, Allgeier A, Lacombe D, Gorlia T, Hoang-Xuan K. van den Bent MJ, et al. Among authors: delattre jy. J Clin Oncol. 2013 Jan 20;31(3):344-50. doi: 10.1200/JCO.2012.43.2229. Epub 2012 Oct 15. J Clin Oncol. 2013. PMID: 23071237 Clinical Trial.
Brainstem tumors.
Laigle-Donadey F, Doz F, Delattre JY. Laigle-Donadey F, et al. Among authors: delattre jy. Handb Clin Neurol. 2012;105:585-605. doi: 10.1016/B978-0-444-53502-3.00010-0. Handb Clin Neurol. 2012. PMID: 22230520 Review. No abstract available.
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.
Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il'yasova D, Kinnersley B, Ostrom QT, Labreche K, Chen Y, Armstrong G, Liu Y, Eckel-Passow JE, Decker PA, Labussière M, Idbaih A, Hoang-Xuan K, Di Stefano AL, Mokhtari K, Delattre JY, Broderick P, Galan P, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Wichmann HE, Schreiber S, Swerdlow A, Lathrop M, Simon M, Sanson M, Andersson U, Rajaraman P, Chanock S, Linet M, Wang Z, Yeager M; GliomaScan Consortium, Wiencke JK, Hansen H, McCoy L, Rice T, Kosel ML, Sicotte H, Amos CI, Bernstein JL, Davis F, Lachance D, Lau C, Merrell RT, Shildkraut J, Ali-Osman F, Sadetzki S, Scheurer M, Shete S, Lai RK, Claus EB, Olson SH, Jenkins RB, Houlston RS, Bondy ML. Melin BS, et al. Among authors: delattre jy. Nat Genet. 2017 May;49(5):789-794. doi: 10.1038/ng.3823. Epub 2017 Mar 27. Nat Genet. 2017. PMID: 28346443 Free PMC article.
Foreword.
Delattre JY. Delattre JY. Rev Neurol (Paris). 2018 Apr;174(4):181. doi: 10.1016/j.neurol.2018.04.001. Rev Neurol (Paris). 2018. PMID: 29678271 No abstract available.
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R; EORTC Quality of Life Group. Postma TJ, et al. Among authors: delattre jy. Eur J Cancer. 2005 May;41(8):1135-9. doi: 10.1016/j.ejca.2005.02.012. Epub 2005 Apr 14. Eur J Cancer. 2005. PMID: 15911236
Dural metastases.
Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY. Laigle-Donadey F, et al. Among authors: delattre jy. J Neurooncol. 2005 Oct;75(1):57-61. doi: 10.1007/s11060-004-8098-1. J Neurooncol. 2005. PMID: 16215816 Review.
641 results